TRIALS BEGIN FOR COVID ANTIBODY DRUG

Highlights:

• The National Institute of Health announced on Tuesday that the trials for the COVID antibody drug will begin.
• There are two trials called ACTIV-2 and ACTIV-3 for both considering the safety and efficacy of an antibody drug called LY-CoV555.
• The drug will examine the patients at some select hospitals all over the globe.

....